HOME >> BIOLOGY >> NEWS
Study: Adults maintain significant improvement in ADHD with long-term use of amphetamine

CHAPEL HILL -- Adults with attention-deficit-hyperactivity disorder treated long term with an extended-release mixed-salts amphetamine medication maintained significant symptom improvement with good tolerance, a new study shows.

University of North Carolina at Chapel Hill researchers presented the study results - from one of the largest trials ever conducted of adult ADHD - today (May 21) at the American Psychiatric Association annual meeting, the world's largest psychiatric conference.

"ADHD is not just a childhood disorder. While hyperactivity may sometimes diminish by adulthood, inattention and impulsivity often remain," said Dr. Richard H. Weisler, adjunct professor of psychiatry at UNC's School of Medicine.

"Our findings suggest that, as in children with ADHD, adults who have this condition can benefit from treatment with this product. This medication can significantly improve adults' ADHD symptoms and, subsequently, their ability to work, socialize and be more productive in everyday activities."

Weisler also is adjunct assistant professor of psychiatry and behavioral sciences at Duke University Medical Center and has a private practice in Raleigh.

Analysis of a four-week, multi-center, phase III pivotal acute double-blind trial data of 248 patients indicated a once-daily extended-release mixed-salts amphetamine medication to be effective and well-tolerated for treating adults with ADHD, Weisler said.

This medication controlled ADHD symptoms up to 12 hours after a single morning dose. The 20-milligram daily dose was determined to be the minimum effective dose for adults with ADHD; for some patients, effectiveness improved as the dose was increased. Improvement in symptom management was maintained throughout the four-week study.

At the end of the trial, the average ADHD Rating Scale (or ADHD-RS) Total Scores, the primary measure of effectiveness, were significantly lower for each medication dose trea
'"/>

Contact: Deb Saine
deborah_saine@unc.edu
919-962-8415
University of North Carolina at Chapel Hill
21-May-2003


Page: 1 2 3 4

Related biology news :

1. Study: Emission of smog ingredients from trees is increasing rapidly
2. Study: A little help from friends makes wounds heal faster
3. Study: Mothers turn fearless when peptide level drops
4. Study: Artificial sweetener may disrupt bodys ability to count calories
5. Study: Mimicking viruses may provide new way to defeat them
6. Study: Stroke victims may retain continuous motion ability
7. Study: Prenatal screening in Haiti region cut syphilis by 75 percent
8. Study: Isoflavone-enriched soy proteins fail to increase bone mineral density in young women
9. Study: Genome-wide scanning unravels complex birth defect
10. Study: Higher energy intake, obesity affects all age groups, not just youths
11. Study: Showering boosts concentrations of potentially hazardous trihalomethanes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/11/2018)... , ... October 09, 2018 , ... ... role in helping market-ready technologies expedite their path to health system adoption and ... full EHR interoperability across all major EHR applications, enabling them to focus on ...
(Date:10/11/2018)... N.Y. (PRWEB) , ... October 09, 2018 , ... ... pump and marine industries, announces the appointment of Mike Cosgrove as Business Manager. , ... will be responsible for the day to day running of the Derby UK facility. ...
(Date:10/11/2018)... ... ... ODSC Europe 2018 - one of Open Data Science Conference , ... September 19-22. , As Europe’s largest applied data science conference, ODSC Europe featured ... Attendees were given key insights and hands-on training in deep learning, machine ...
Breaking Biology News(10 mins):
(Date:10/2/2018)... ... October 02, 2018 , ... Finalists for ... (Locus Bio-Energy) AssurEOR product line was chosen for its advancements in the production ... honor leading innovations in upstream oil applications that are positively impacting the industry. ...
(Date:10/2/2018)... ... October 02, 2018 , ... The Alliance for ... have initiated validation of standards and testing of procedures for voluntary accreditation of ... Kennedy, ACRES VP for Quality Management Systems and Chief Quality Officer, is underway ...
(Date:9/28/2018)... ... September 28, 2018 , ... GlycoMark®, Inc. has ... of the GlycoMark test, the only FDA-cleared blood test specific to detecting recent ... promote and offer the GlycoMark test to its network of physicians through its ...
(Date:9/27/2018)... ... September 26, 2018 , ... NDA ... Cimler, a senior quality, regulatory, and in vitro diagnostic device expert with more ... industry has joined the firm as an Expert Consultant. Her experience includes leadership ...
Breaking Biology Technology:
Cached News: